Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
10.61MXN
2.09 BMXN
26.64 BMXN
111.76 M
About Globus Medical, Inc.
Sector
Industry
CEO
Daniel T. Scavilla
Website
Headquarters
Audubon
Employees (FY)
5 K
Founded
2003
FIGI
BBG00KVDXPD6
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange GLOBUS MEDICAL, INC stocks are traded under the ticker GMED.
GMED stock has risen by 1.68% compared to the previous week, the month change is a 1.68% rise, over the last year GLOBUS MEDICAL, INC has showed a 1.68% increase.
We've gathered analysts' opinions on GLOBUS MEDICAL, INC future price: according to them, GMED price has a max estimate of 1562.61 MXN and a min estimate of 1011.10 MXN. Watch GMED chart and read a more detailed GLOBUS MEDICAL, INC stock forecast: see what analysts think of GLOBUS MEDICAL, INC and suggest that you do with its stocks.
GMED stock is 1.68% volatile and has beta coefficient of 1.27. Track GLOBUS MEDICAL, INC stock price on the chart and check out the list of the most volatile stocks — is GLOBUS MEDICAL, INC there?
Today GLOBUS MEDICAL, INC has the market capitalization of 168.76 B, it has increased by 2.33% over the last week.
Yes, you can track GLOBUS MEDICAL, INC financials in yearly and quarterly reports right on TradingView.
GLOBUS MEDICAL, INC is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
GMED earnings for the last quarter are 11.93 MXN per share, whereas the estimation was 9.40 MXN resulting in a 26.98% surprise. The estimated earnings for the next quarter are 12.42 MXN per share. See more details about GLOBUS MEDICAL, INC earnings.
GLOBUS MEDICAL, INC revenue for the last quarter amounts to 10.05 B MXN, despite the estimated figure of 9.73 B MXN. In the next quarter, revenue is expected to reach 11.29 B MXN.
GMED net income for the last quarter is −117.95 M MXN, while the quarter before that showed 255.37 M MXN of net income which accounts for −146.19% change. Track more GLOBUS MEDICAL, INC financial stats to get the full picture.
No, GMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 2, 2024, the company has 5.00 K employees. See our rating of the largest employees — is GLOBUS MEDICAL, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLOBUS MEDICAL, INC EBITDA is 6.15 B MXN, and current EBITDA margin is 22.10%. See more stats in GLOBUS MEDICAL, INC financial statements.
Like other stocks, GMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLOBUS MEDICAL, INC stock right from TradingView charts — choose your broker and connect to your account.